Clinical Trial Update: Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for a vitamin C plus G-FLIP regimen (low-dose gemcitabine, 5-FU, leucovorin, irinotecan, oxaliplatin) in pancreatic cancer; the Phase 2 stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Vitamin C (ascorbic acid) (ascorbic acid)

Snippet

Sponsor: Bruckner Oncology | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-08-14